Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

New ASPIRE data boosts Amgen’s Kyprolis

Trial results presented at ASH show drug can be safely added to standard chemotherapy

- PMLiVE

UPDATE: Merck to acquire Cubist for $8.4bn

Will expand company's presence in antibiotics

US doctors support digital health technology

Mobile devices and apps find favour in new survey

- PMLiVE

Pfizer’s CMO joins board of Tenet

Freda Lewis-Hall to advise healthcare services firm

EU flag

Life expectancy continues to rise in Europe

EC report shows five-year improvement since 1990

- PMLiVE

Crisis communications: managing the next pandemic

Whether responding to the Ebola outbreak or the next unknown health threat, your organisation must be prepared to communicate effectively and quickly

- PMLiVE

Galderma removed from list of companies compliant to UK Code

Follows breach of pharma standards

- PMLiVE

France’s taxes make CEO search harder, says Sanofi chairman

Weinberg tells former minister Arnaud Montebourgthat that tax burden is a turn-off for senior executives

- PMLiVE

GSK holds on to older products

No suitable buyer found for portfolio of established medicines

- PMLiVE

Jakafi cleared for bone marrow disorder by FDA

Approval of Incyte drug could achieve it blockbuster status

Idera Pharmaceuticals names new CEO

Vincent Milano was most recently CEO of Viropharma

Bristol-Myers Squibb (BMS) building

BMS to fund hepatitis projects in China and India

Pharma firm awards nine grants to support care for high-risk patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links